经导管三尖瓣介入治疗最佳结果定义:Tri-QOL研究
Tri-QOL研究二次分析纳入6项单臂研究共1056例重度及以上三尖瓣反流患者,评估TTVI术后三尖瓣反流(TR)减少程度与KCCQ-OS改善的关系。结果显示TR减少与健康状态改善强相关,多数患者TR减少3级后改善趋于平台;支持以轻度及以下TR为治疗目标,基线大量TR者达到中度TR即可。
要点
- TTVI术后TR减少程度与KCCQ-OS改善强相关,无一致证据显示TR低于某阈值后不再改善。
- 多数患者TR减少超过3级后健康状态额外改善有限。
- 支持以轻度及以下TR为TTVI目标,基线大量TR者达到中度TR可能已足够。
核心结论
- TTVI后健康状态改善与TR减少程度相关性最强,多数患者TR减少超过3级后额外改善有限。
- 研究支持以轻度及以下TR作为TTVI目标,基线大量TR患者达到中度TR可能已足够。
研究设计与样本
- Tri-QOL研究的二次观察性分析,使用6项TTVI单臂研究的患者水平数据,共1056例重度及以上TR患者。
- 采用多变量模型分析KCCQ-OS变化与TR分级的关联,调整年龄、性别、慢性肺病和基线KCCQ-OS。
主要发现
- 1056例患者平均年龄79.1±7.1岁,女性占60.3%,基线KCCQ-OS均值49.5±22.3。
- 基线TR分级:重度33.5%、大量35.9%、极大量30.6%。
- TTVI后1个月TR分级:无/微量21.7%、轻度27.2%、中度28.1%、重度及以上23.1%;KCCQ-OS平均变化17.0±21.3分。
- 多变量模型显示TR减少与KCCQ-OS改善强相关,无一致证据显示TR低于某阈值后不再改善。
- 基线极大量TR患者达到中度及以下TR(即较基线改善3级)后,健康状态改善趋于平台。
临床怎么用
- TTVI术中应追求将TR降至轻度及以下以最大化健康状态获益。
- 对基线极大量TR患者,达到中度TR即可视为可接受的介入结果。
局限性
- 为二次观察性分析,非随机对照设计。
- 仅纳入6项单臂研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent randomized trials have demonstrated that for patients with severe tricuspid regurgitation (TR), transcatheter tricuspid valve interventions (TTVI) improve patients' symptoms, function, and quality of life and that the amount of health status improvement correlates with the extent of TR reduction. Defining this relationship in greater detail can potentially provide insight into device selection and patient-specific treatment goals. We therefore sought to better understand the relationship between both baseline TR severity and change in TR after TTVI and the extent of improvement in health status after TTVI. METHODS: As part of the Tri-QOL (Kansas City Cardiomyopathy Questionnaire Validation in Tricuspid Valve Disease) study, data from 11 studies of TTVI devices were transferred to the US Food and Drug Administration to harmonize and anonymize before analysis by an independent center. This secondary, observational analysis used patient-level data from the 6 single-arm studies of patients who underwent TTVI to explore the association of change in KCCQ-OS with TR grade using multivariable models, adjusted for age, sex, chronic lung disease, and baseline KCCQ-OS. The primary model included TR grade at baseline, TR grade at 1 month, and the interaction between the two. RESULTS: Among 1056 patients with ≥severe TR who underwent TTVI, mean age was 79.1±7.1 years, 60.3% were female, and mean baseline Kansas City Cardiomyopathy Questionnaire-overall summary score [KCCQ-OS] was 49.5±22.3. Baseline TR grade was severe in 33.5%, massive in 35.9%, and torrential in 30.6%. One-month after TTVI, TR was none/trace in 21.7%, mild in 27.2%, moderate in 28.1%, and ≥evere in 23.1%, while the mean change in KCCQ-OS was 17.0±21.3 points. In a multivariable model that included TR grade at baseline, TR grade at 1 month, and their interaction, there was a strong association between reduction in TR and improvement in KCCQ-OS, with no consistent evidence of a threshold of TR grade below which there was no further improvement in KCCQ-OS. However, among patients with baseline torrential TR, the extent of health status improvement plateaued for patients achieving moderate or less TR at 1 month (ie, a 3-grade improvement from baseline). CONCLUSIONS: Health status improvement after TTVI was most strongly associated with the degree of TR reduction, although there was minimal additional improvement for most patients beyond a 3-grade reduction in TR. These findings support the goal of achieving mild or less TR with TTVI, although patients with torrential TR at baseline may be well served if moderate TR can be achieved.
引用
- Arnold SV, Spertus JA, Gosch K, et al. Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study. Circulation. 2026. PMID: 41628259. doi:10.1161/CIRCULATIONAHA.125.076542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。